Europlasma S.A. (EPA:ALEUP)
0.0390
-0.0020 (-4.88%)
Feb 12, 2026, 3:03 PM CET
Europlasma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 10.43 | 1.74 | 1.16 | 2.41 | 2.48 | 4.16 |
Short-Term Investments | 0.09 | 0 | 0 | 0.01 | - | 0.01 |
Cash & Short-Term Investments | 10.51 | 1.75 | 1.16 | 2.42 | 2.48 | 4.17 |
Cash Growth | 570.90% | 50.56% | -52.06% | -2.26% | -40.58% | 52.63% |
Accounts Receivable | 12.2 | 8.7 | 2.47 | 3.17 | 0.94 | 1.27 |
Other Receivables | 5.86 | 5.49 | 2.29 | 3.94 | 4.53 | 5.11 |
Receivables | 18.06 | 16.68 | 4.89 | 7.38 | 5.68 | 6.64 |
Inventory | 21.73 | 17.84 | 7.87 | 6.63 | 3.01 | 0.82 |
Prepaid Expenses | 0.5 | 0.61 | 0.19 | 0.28 | 1.78 | 0.17 |
Other Current Assets | 4.13 | 1.78 | 0.51 | 0.3 | 0.41 | 0.3 |
Total Current Assets | 54.93 | 38.66 | 14.61 | 17 | 13.36 | 12.1 |
Property, Plant & Equipment | 24.72 | 19.21 | 24.18 | 29 | 18.81 | 8.18 |
Long-Term Investments | - | - | - | - | 0.01 | 0 |
Goodwill | 0.08 | 0.08 | - | - | 0.01 | 0.01 |
Other Intangible Assets | 0.14 | 0.16 | 0.11 | 0.13 | 0.13 | 0.04 |
Long-Term Deferred Tax Assets | 0.01 | 0.02 | 0.06 | 0.95 | 0.4 | - |
Long-Term Deferred Charges | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Other Long-Term Assets | 0.31 | 0.32 | 0 | 0.07 | 0.34 | 0.02 |
Total Assets | 85.37 | 62.9 | 45.26 | 54.67 | 40.44 | 26.3 |
Accounts Payable | 16.97 | 11.23 | 6.49 | 3.87 | 2.97 | 2.19 |
Accrued Expenses | 11.06 | 7.27 | 4.31 | 6.04 | 6.04 | 8.45 |
Short-Term Debt | - | - | 0 | 0 | 0.01 | 0.01 |
Current Portion of Long-Term Debt | 3.92 | 2.28 | 5.85 | 3.21 | 0.04 | 5.87 |
Current Portion of Leases | 1.51 | 1.21 | 0.66 | 1.31 | 1.23 | 0.5 |
Current Income Taxes Payable | 0.7 | 0.29 | - | 0.03 | 0.04 | - |
Current Unearned Revenue | 16.72 | 8.89 | 6.17 | 7.25 | 7.39 | 13.59 |
Other Current Liabilities | 17.53 | 19.11 | 7.6 | 5.75 | 3.95 | 1.86 |
Total Current Liabilities | 68.41 | 50.3 | 31.08 | 27.44 | 21.65 | 32.47 |
Long-Term Debt | 9.1 | 7.35 | 3.62 | 2.31 | 0.5 | 0.44 |
Long-Term Leases | 2.72 | 2.83 | 2.6 | 1.15 | 2.42 | 0.84 |
Pension & Post-Retirement Benefits | 5.08 | 2.1 | 0.68 | 0.65 | 0.77 | 0.73 |
Long-Term Deferred Tax Liabilities | 1.31 | 1.7 | 3.59 | 4.84 | 1.88 | - |
Other Long-Term Liabilities | 19.55 | 9.78 | 8.45 | 12.47 | 8.74 | 8.27 |
Total Liabilities | 106.17 | 74.05 | 50.02 | 48.86 | 35.97 | 42.75 |
Common Stock | 1.4 | 52.64 | 3.05 | 4.09 | 140.65 | 20.9 |
Additional Paid-In Capital | 72.99 | 72.99 | 72.52 | 72.44 | 68.02 | 67.8 |
Retained Earnings | -256.9 | -229.92 | -214.63 | -199.89 | -183.97 | -171.29 |
Comprehensive Income & Other | 163.56 | 93.88 | 135.06 | 129.92 | -19.35 | 67.02 |
Total Common Equity | -18.94 | -10.41 | -4.01 | 6.56 | 5.35 | -15.58 |
Minority Interest | -1.86 | -0.74 | -0.74 | -0.74 | -0.88 | -0.88 |
Shareholders' Equity | -20.8 | -11.15 | -4.75 | 5.82 | 4.47 | -16.45 |
Total Liabilities & Equity | 85.37 | 62.9 | 45.26 | 54.67 | 40.44 | 26.3 |
Total Debt | 17.25 | 13.67 | 12.73 | 7.97 | 4.19 | 7.66 |
Net Cash (Debt) | -6.73 | -11.92 | -11.57 | -5.55 | -1.71 | -3.49 |
Filing Date Shares Outstanding | 0.56 | 0.02 | - | - | - | - |
Total Common Shares Outstanding | 0.56 | 0.02 | - | - | - | - |
Working Capital | -13.48 | -11.64 | -16.47 | -10.44 | -8.29 | -20.37 |
Book Value Per Share | -33.86 | -494.35 | - | - | - | - |
Tangible Book Value | -19.17 | -10.65 | -4.12 | 6.44 | 5.22 | -15.62 |
Tangible Book Value Per Share | -34.26 | -505.60 | - | - | - | - |
Land | 1.13 | 0.18 | 1 | 1 | 1 | - |
Buildings | 16.66 | 15.68 | 13.4 | 14.69 | 10.36 | 9.35 |
Machinery | 52.13 | 48.81 | 46.36 | 66.89 | 61.64 | 53.52 |
Construction In Progress | 3.84 | 3.65 | 1.84 | 2.56 | 4.82 | 4.02 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.